Molbio Diagnostics IPO Final Subscription Status
Final subscription data from BSE & NSE with category-wise breakdowns
📈 Building steadily
📈 GMP Today
🎟️ Allotment Status
📄 Full IPO Details
Listed at BSE & NSE · Registrar: Kfin Technologies Ltd.
Price: ₹768 - ₹807
Lot: 18
Min: ₹14,526
Period: 10 Aug - 12 Aug
Subscribed
70.24x
Total Demand
₹46,244 Cr
Applications
—
Build by Day
0.83x
→
3.11x
→
70.24x
Subscription (Shares)
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 23,25,145 | 43,33,82,148 | 186.39 |
| NII | 17,43,860 | 8,68,32,324 | 49.79 |
| bNII (>10 Lakh) | 11,62,574 | 5,90,76,594 | 50.82 |
| sNII (2-10 Lakh) | 5,81,286 | 2,77,55,730 | 47.75 |
| Retail | 40,69,005 | 5,25,53,898 | 12.92 |
| Employee Reserved | 20,519 | 2,71,674 | 13.24 |
| TOTAL | 81,58,529 | 57,30,40,044 | 70.24 |
Application Breakup
| Category | Reserved | Applications | Times |
|---|---|---|---|
| NII | 6,920 | 3,44,573 | 49.79 |
| bNII (>10 Lakh) | 4,613 | 47,566 | 10.31 |
| sNII (2-10 Lakh) | 2,307 | 1,10,142 | 47.74 |
| Retail | 2,26,056 | 29,19,661 | 12.92 |
| Employee Reserved | 1,140 | 15,093 | 13.24 |
| TOTAL | 2,41,036 | 34,37,035 | 14.26 |
Subscription (Crores)
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIB | 187.64 | 34,973.94 | 186.39 |
| NII | 140.73 | 7,007.37 | 49.79 |
| bNII (>10 Lakh) | 93.82 | 4,767.48 | 50.82 |
| sNII (2-10 Lakh) | 46.91 | 2,239.89 | 47.75 |
| Retail | 328.37 | 4,241.10 | 12.92 |
| Employee Reserved | 1.66 | 21.92 | 13.24 |
| TOTAL | 658.39 | 46,244.33 | 70.24 |
Day-wise Subscription
How demand built up across the bidding days — subscription at the end of each day.
Each panel uses its own scale; compare the numbers, not bar heights, across categories.
| Day | QIB | NII | bNII | sNII | Retail | Emp. | Total |
|---|---|---|---|---|---|---|---|
| Day 1 10 Aug | 1.00x | 0.73x | 0.70x | 0.80x | 0.77x | 2.12x | 0.83x |
| Day 2 11 Aug | 1.39x | 5.21x | 4.31x | 7.01x | 3.18x | 4.78x | 3.11x |
| Day 3 12 Aug | 186.39x | 49.79x | 50.82x | 47.75x | 12.92x | 13.24x | 70.24x |
Estimated Allotment Chance
Retail
8.8%
(12.92x subscribed)
Low chance
S-HNI (2-10L)
2.1%
(47.75x subscribed)
Low chance
B-HNI (>10L)
9.7%
(50.82x subscribed)
Low chance
Employee
7.6%
(13.24x subscribed)
Low chance
about 9 in 100 retail applicants are likely to get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results.
Actual allotment depends on the number of applications received and SEBI's allotment rules —
draw of lots for Retail, Employee and NII; proportionate for QIB.
Disclaimer: Subscription data is sourced from BSE and NSE.
Please verify with official exchange websites before making any investment decisions.
This information is for educational purposes only and should not be construed as investment advice.
Molbio Diagnostics IPO Subscription — Detailed Analysis
Where Molbio Diagnostics Subscription Finished
Molbio Diagnostics IPO was subscribed 70.24 times overall by the close of bidding — a heavily oversubscribed level that signals strong investor demand.
Molbio Diagnostics IPO Subscription — FAQs
Molbio Diagnostics IPO was subscribed 70.24 times overall by the close of bidding.
Molbio Diagnostics IPO was open for subscription from August 10, 2026 to August 12, 2026.
The price band for Molbio Diagnostics IPO is ₹768 - ₹807 per share.
New to subscription data? The hub explains what QIB, NII and Retail mean and how to read the table. For allotment odds from these numbers, see the allotment chances calculator or our IPO allotment process explainer.
Explore More
Quick links to all IPO sections
Open IPO
Live now
Best IPO Today
Data scores
Upcoming IPO
Coming soon
IPO Calendar
Dates & schedule
Closed IPO
Allotment pending
Listed IPO
Listing gains
IPO GMP
Grey market premium
Subscription
Live bidding data
Allotment
Check status
Allotment Chances
Your odds
SME IPO
Small & medium
Mainboard IPO
Large cap
Performance
Listing returns
Learn
IPO guides